He is a molecular and cellular biologist with a strong background in Alzheimer’s disease. He obtained a MS in Pharmaceutics from the University of Florida where he worked on gene therapy for Alzheimer’s disease. Currently, he is working on the functional characterization of novel genes and pathways involved in Alzheimer’s and Parkinson’s diseases.